"We hope to witness the making of the vaccine soon in our country," Khavazi said.
Our colleagues have carried out extensive research under the direct auspices of the health ministry to gain access to vaccine, he said, adding, “The vaccine has undergone all its animal-phase tests and we are preparing documents and rendering them to the health ministry."
In relevant remarks on August 19, Head of Tehran Headquarters for Anti-COVID-19 Campaign Alireza Zali announced that the results of the human trials phase of the Iranian COVID-19 vaccine will become evident in the coming months.
"Three centers in Iran are working on vaccines and animal trials of the Iranian vaccine have been carried out successfully, and we will probably see the results of the human testing phase in November," Zali said.
He pointed out that one of the top European companies in the field of vaccine production recently said that the coronavirus vaccine can provide safety for only 73 days.
Regarding the restrictions on coronavirus in the Iranian capital, Zali said that many restrictions will stay in place until autumn, adding, "We are trying to prevent an increase in the spread of the disease by holding schools and universities electronically in the autumn."
Pointing to the favorable situation of COVID-19 management in Tehran, he said that at the beginning of the outbreak of the disease, the rate of the observance of health protocols in the capital was 65 percent, but unfortunately with the end of the first wave of the disease, this number declined to nine percent. But currently, the rate of observance of protocols in Tehran is 73 percent
Regarding the buying of the Russian vaccine, Zali said that after the approval of international organizations such as the World Health Organization, Iran will take action to buy this vaccine.
"We have no problem in producing drugs and we produce two drugs, Favipiravir and Remdesivir, and next week the mass production of these two drugs will begin and we are self-sufficient in producing masks," he concluded.
In relevant remarks earlier this month, Head of Pasteur Institute of Iran Alireza Biglari announced that the country’s experts are studying the possibility for starting the human trial phase for the home-made coronavirus vaccine following positive animal tests results.
“Fortunately, two of our knowledge-based companies have carried out good studies in this field and their vaccine (formula) is in the phase of animal tests and in case of positive results, they will enter the phase of human trial research,” Biglari told reporters.
Meantime, a senior member of the scientific committee of the national coronavirus campaign headquarters, Minou Mohrez, told FNA that the Iranian researchers have made progress in the production of anti-COVID-19 virus.
She said that the Iran-made coronavirus vaccine has successfully passed animal tests, and studies for human trials are being carried out.
Moreover, in early August, Iranian Health Minister Saeed Namaki said that the country’s medical specialists and scientists are now testing the home-made coronavirus vaccine on humans.
“Along with other world states, we have started work on [coronavirus] vaccine in our knowledge-based companies, Pasteur Institute of Iran and Razi Institute,” Namaki told reporters in a virtual meeting.
“Today, I can say that this multilateral cooperation has made some progress in developing three to four vaccines and these vaccines have passed tests on animals and have entered the human trial phase,” he added.
Namaki said that the Iranian government has also adopted the necessary action to purchase vaccine from the countries that might manage to develop it sooner than Iran.
Earlier this month, Namaki had announced that 5 groups of specialized researchers in Iran were trying to find the coronavirus vaccine, adding that the clinical studies on the vaccine would start soon.
“At present, at least 5 groups of highly skilled Iranian groups are working on production of [coronavirus] vaccine in Iran and clinical studies on the vaccine’s effect on humans is due to start very soon,” Namaki said in a video conference with his Nicaraguan counterpart Martha Reyes Alvarez.
He added that Iran has also produced Favipiravir and Remdesivir, two drugs believed to be of help in fighting the coronavirus, saying that the Iran-made Remdesivir will be provided to the patients soon.
Namaki said that Iran produces 97% of drugs needed in the country, stressing readiness to share experiences with Nicaragua in the field of health and hygiene.